BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.20), $0.72 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.